We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WTTR:NYSESelect Water Solutions, Inc. Analysis

Data as of 2026-05-11 - not real-time

$16.80

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading above its short‑ and medium‑term moving averages while remaining below the long‑term average, and the MACD histogram has turned positive, indicating bullish momentum. The RSI sits in a comfortable mid‑range, suggesting room for further upside without immediate overbought pressure. However, the 30‑day volatility is elevated and volume trends are weakening, which could amplify short‑term price swings. The beta is slightly above one, meaning the equity moves in line with, or a touch more than, the broader market.
Fundamental outlook: Valuation metrics are stretched, with a trailing P/E that is markedly higher than the industry norm and a price‑to‑book ratio well above one, while the DCF‑derived fair value sits below the current market price. Profitability is thin, free cash flow is negative, and the company carries a high debt load relative to equity, raising concerns about balance‑sheet resilience. The dividend payout exceeds earnings, flagging sustainability issues despite the modest yield. Nonetheless, management is projecting robust growth in the water‑infrastructure segment, which could improve earnings trajectory if realized.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (price above SMAs, positive MACD)
  • Recent price dip offering a more attractive entry point
  • High market sentiment reflected by extreme greed index

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong growth guidance for water‑infrastructure segment
  • Persistently high valuation relative to earnings and peers
  • Elevated volatility and weakening volume trends

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Overvaluation indicated by DCF fair value below market price
  • Negative free cash flow and high debt‑to‑equity ratio
  • Unsustainable dividend payout exceeding earnings

Key Metrics & Analysis

Financial Health

Revenue Growth-2.30%
Profit Margin1.54%
P/E Ratio80.0
ROE2.10%
ROA1.71%
Debt/Equity25.48
P/B Ratio2.2
Op. Cash Flow$230.0M
Free Cash Flow$-123207128
Industry P/E20.3

Technical Analysis

TrendBullish
RSI59.5
Support$14.22
Resistance$18.50
MA 20$16.16
MA 50$15.20
MA 200$11.76
MACDBullish
VolumeDecreasing
Fear & Greed Index90.73

Valuation

Fair Value$13.61
Target Price$19.60
Upside/Downside16.67%
GradeOvervalued
TypeGrowth
Dividend Yield1.67%

Risk Assessment

Beta1.07
Volatility36.78%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.